Recipharm Lifesciences India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -19.89%
- Profit Growth -15.60%
- Ebitda 43.48%
- Net Worth 0.01%
- Total Assets 0.01%
About Recipharm Lifesciences India
Recipharm Lifesciences India Private Limited (RLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 February 2017 (Eight years and two months 23 days old ). Its registered office is in Sirmaur, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Sidhwani, Emmanuel Grand, and Suresh Ganachari serve as directors at the Company.
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909HP2017PTC006464
- Company No.
006464
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Pharma
Recipharm Lifesciences India Private Limited
Explore comprehensive data for Recipharm Lifesciences India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Recipharm Lifesciences India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Sidhwani | Director | 22-Feb-2023 | Current |
| Emmanuel Grand | Director | 06-Jan-2023 | Current |
Suresh Ganachari  | Director | 28-Nov-2022 | Current |
Financial Performance of Recipharm Lifesciences India.
Recipharm Lifesciences India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.89% decrease. The company also saw a substantial fall in profitability, with a 15.6% decrease in profit. The company's net worth moved up by a moderate rise of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Recipharm Lifesciences India?
In 2022, Recipharm Lifesciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Recipharm Pharmaservices Private LimitedSuresh Ganachari is a mutual person
Recipharm Holding India Private LimitedRohit Sidhwani, Emmanuel Grand and 1 more are mutual person
Nitin Lifesciences LimitedSuresh Ganachari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Recipharm Lifesciences India?
Unlock and access historical data on people associated with Recipharm Lifesciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recipharm Lifesciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recipharm Lifesciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Recipharm Lifesciences India
Recent activity within the organization
- Annual General Meeting
Recipharm Lifesciences India Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Recipharm Lifesciences India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Himachal Pradesh.
- Director Appointment
Rohit Kishore Sidhwani was appointed as a Director was appointed as a Director on 22 Feb 2023 & has been associated with this company since 2 years 2 months .
- Director Appointment
Emmanuel Nicolas Grand was appointed as a Director was appointed as a Director on 06 Jan 2023 & has been associated with this company since 2 years 3 months .
- Director Appointment
Suresh Nagappa Ganachari was appointed as a Director was appointed as a Director on 28 Nov 2022 & has been associated with this company since 2 years 4 months .
- Company Incorporation
Recipharm Lifesciences India Private Limited was registered on 01 Feb 2017 with Roc Himachal Pradesh & aged 8 years 2 months as per MCA records.
Recent News, Updates & Announcement
- When Puzzle Pieces Align: Recipharm Acquires Nitin Lifesciences in Boss Move by Sobti Family #AcquisitionGoals #Recipharm #NitinLifesciences #SobtiFamily.
When you finally get the last piece of the puzzle. #AcquisitionGoals #Recipharm #NitinLifesciences #SobtiFamily #BossMoves.
Frequently asked questions
What is the Incorporation or founding date of Recipharm Lifesciences India Private Limited?
Recipharm Lifesciences India Private Limited was incorporated on 01 Feb 2017.
What is authorized share capital and paid-up capital of Recipharm Lifesciences India Private Limited?
The authorized share capital of Recipharm Lifesciences India Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Recipharm Lifesciences India Private Limited?
Currently 3 directors are associated with Recipharm Lifesciences India Private Limited.
- Rohit Kishore Sidhwani
- Emmanuel Nicolas Grand
- Suresh Nagappa Ganachari
What is the registered address of Recipharm Lifesciences India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Recipharm Lifesciences India Private Limited is Rampur Ghat Road Vill Kunja District Sirmaur India, Poanta Sahib, Himachal Pradesh, 173025.
What is the corporate identification number (CIN) and company number of Recipharm Lifesciences India Private Limited?
The corporate identification number (CIN) of Recipharm Lifesciences India Private Limited is U51909HP2017PTC006464 and the company number is 006464 as per Ministry of Corporate Affairs (MCA).
What is the official website of Recipharm Lifesciences India Private Limited?
The Official website of Recipharm Lifesciences India Private Limited is https://www.recipharm.com
What has been the recent revenue trend for Recipharm Lifesciences India Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Recipharm Lifesciences India Private Limited has fallen by -19.89%.
What change has been observed in the net worth of Recipharm Lifesciences India Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Recipharm Lifesciences India Private Limited has experienced an upsurge of 0.01%.
When was the last Balance Sheet of Recipharm Lifesciences India Private Limited filed with the ROC?
The most recent Balance Sheet for Recipharm Lifesciences India Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Thomas ElderedDirector
Lisa LundbergDirectorKS
Ketki SaveDirectorJH
Jean HilaireDirectorMR
Mark RoystonDirector
Similar Companies Based on Pharmaceutical Retailers & Distributors
Wellness Forever Medicare Limited Mumbai, Maharashtra, India
Sun Pharma Distributors Limited Mumbai, Maharashtra, India
Novartis Healthcare Private Limited Mumbai, Maharashtra, India
Mylan Pharmaceuticals Private Limited Hyderabad, Telangana, India
Msd Pharmaceuticals Private Limited New Delhi, Delhi, India
Aster Dm Healthcare Limited Bangaluru, Karnataka, India
Reckitt Benckiser Healthcare India Private Limited Gurugram, Haryana, India
Apollo Hospitals Enterprise Limited Chennai, Tamil Nadu, India